All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
ABBV total return snapshot: ABBV returned +27.56% over the past year and +27.00% YTD, with dividends reinvested. Since Dec. 10, 2012, ABBV is up +1,293.41% in nominal total return, or +20.96%/yr, and is currently at its total-return high.
Data ending Wed Oct. 14, 2026
| Mon 2012-12-10💬 to Wed 2026-10-14 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+1,293.41%
+20.96%/yr |
+17.89%/yr
R2=0.965 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10💬 to Wed 2026-10-14 |
Start
Value |
End
Value |
|---|---|---|
| ABBV × |
$10,000.00
2012-12-10 |
$139,341.24
2026-10-14 |
| YTD | YoY | |
|---|---|---|
| ABBV × | +27.00% | +27.56% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| ABBV × |
—
on 2026-10-14 |
−45.09%
on 2019-08-15 from 2018-01-26 peak |
| Period ending Wed 2026-10-14 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| ABBV × | +27.56% |
+54.74% +24.39%/yr |
+110.41% +28.14%/yr |
+208.99% +25.31%/yr |
+603.78% +21.55%/yr |
| Year | ABBV |
|---|---|
| 2026 (YTD) | +27.00% |
| 2025 | +33.08% |
| 2024 | +18.87% |
| 2023 | −0.23% |
| 2022 | +24.01% |
| 2021 | +32.43% |
| 2020 | +27.72% |
| 2019 | +1.47% |
| 2018 | −0.96% |
| 2017 | +60.07% |
| 2016 | +9.79% |
| 2015 | −6.50% |
| 2014 | +27.92% |
| 2013 | +60.77% |
| 2012 | −2.40% |
